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The term folate is used to include both the forms 
found in natural foods and synthetic folic acid 
added to fortify foods. Folate-deficient megaloblastic 
anaemia was recognised in the early 1940s, and was 
the only known effect of folate deficiency until the 
1969 report that folic acid supplementation of pregnant women 
could reduce the incidence of prematurity.[1] The report[2] by the UK 
Medical Research Council in 1993 that increasing the folic acid intake 
of pregnant women reduced the incidence of neural tube defects 
(NTDs) in their offspring led to the introduction of folate food 
fortification (FFF) in many countries. In recent years, the literature 
on FFF has been dominated by its effect on the prevalence of NTDs, 
and it is perhaps timely to consider some of the haematological 
implications of FFF.
Historical aspects
Reports of folate-deficient megaloblastic anaemia in pregnant and 
lactating women in hospitals in South Africa were published in 
the early 1950s and led to a number of population surveys of folate 
nutrition. A high prevalence of deficiency was reported in pregnant 
and lactating women, non-pregnant women, adult males, older 
people and preschool children. Deficiency in pregnancy and lactation 
can be prevented by supplementation with folic acid tablets supplied 
at antenatal and postnatal clinics, but many pregnant women, 
particularly in rural areas, did not attend these clinics at that time. 
Refining of the staple maize meal markedly reduces its folate content, 
and it was proposed that fortification with folic acid was warranted 
to combat the widespread deficiency identified. The first studies to 
test the feasibility of FFF were done in South Africa, completed in 
1973 and published by the end of 1975, and have been summarised 
by Colman.[3] Folic acid added to maize meal, rice or bread cooked in 
the traditional manner did not alter the colour or taste of the food, 
and was absorbed adequately. Maize meal with 300 μg, 500 μg or 
1 000 μg of folic acid per 30 g meal added before cooking, and bread 
with 900 μg/100 g added before baking, produced a significant rise in 
serum and red cell folate concentrations in women in late pregnancy. 
Maize meal with 300 μg folic acid added prevented the progression 
of folate depletion in late pregnancy. In families given fortified maize 
meal for use in the home, red cell folate levels rose significantly. 
These results indicated that fortification of maize meal and bread 
with folic acid was feasible, and that it was effective in combating 
folate deficiency. These studies prompted the South African Medical 
Research Council’s Food Fortification Committee to recommend 
fortification of maize meal with folic acid in 1976. An approach to the 
milling industry to fortify the meal voluntarily was rejected, and the 
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It is a privilege to participate in the Festschrift in honour of a 
longstanding colleague and friend, Professor Trefor Jenkins. The 
doyen of both modern clinical and population genetics in South 
Africa, he is unique in having attained international recognition 
for his contributions to both fields. As the first Professor of Human 
Genetics at the School of Pathology of the South African Institute 
for Medical Research and the University of the Wiwatersrand, 
Johannesburg, he built up an impressive department and trained 
numerous young workers, many of whom have gone on to assume 
important positions in the field. A charismatic lecturer and teacher, 
he expertly communicates his wide knowledge to both students 
and the lay public. In addition to his outstanding academic 
achievements, he is a prominent medical ethicist, with a deep 
concern for human rights and the underprivileged. His numerous 
efforts to attain justice and equal status for all his colleagues 
during the apartheid era have been recognised both locally and 
internationally. He has enriched the lives of all who have been 
fortunate to know him.
With Professor Jenkins’ concern for the underprivileged, it would 
not seem out of place to devote this paper to the topic of folate food 
fortification, the benefits of which are aimed primarily at low-
income populations.
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government of the day declined to legislate that the industry replace 
those vitamins that processing removes so effectively from the meal.
Following the reports of the effect of folic acid in reducing the 
incidence of NTDs, in 1998 the USA legislated for the mandatory folic 
acid fortification of flour, cornmeal, rice and pasta in a concentration 
of 140 μg/100 g; this example was followed by many other countries, 
and by 2012 a total of some 66 had instituted or agreed to mandatory 
FFF, within the range of 100 - 300 μg folic acid per 100 g. The 
amount of folic acid to be added was designed to increase the folic 
acid intake to 400 μg/day by women who might become pregnant. 
The South African Government introduced legislation in 2003 for 
the mandatory fortification of maize meal and wheat flour, at a 
concentration of 150 μg/100 g. National programmes to mandate FFF, 
including that in South Africa, have reduced the prevalence of NTDs 
significantly worldwide.
Effect of FFF on tests of 
folate nutrition
The hallmark of folate deficiency is macrocytic anaemia with 
megaloblastic change in the bone marrow. Anaemia and macrocytosis, 
however, are late manifestations and relatively insensitive, nonspecific 
indicators of deficiency. Measurement of serum folate (SF) and red 
cell folate (RCF) concentrations enables deficiency to be recognised 
well before the onset of haematological changes. SF is predominantly a 
sensitive marker of dietary folate intake, falls rapidly into the deficient 
range during deprivation, and is the earliest indicator of folate 
imbalance, before depletion of folate stores. SF is subnormal both 
when intake is deficient and when body stores are depleted, and does 
not distinguish between the two. RCF, which reflects folate nutrition 
at the time of formation of red cells (the folate concentration of which 
remains constant throughout their 120-day lifespan), is not affected 
by current folate intake, and is therefore a more specific index of 
folate nutrition. Folate is required for the conversion of homocysteine 
(Hcy) to methionine, and Hcy accumulates in the plasma in folate 
deficiency. Measurement of plasma Hcy is a surrogate test for folate 
deficiency, but the test is nonspecific as there are numerous other 
causes of raised Hcy.
The US National Health and Nutrition Examination Survey 
(NHANES) has monitored the folate status of the US population 
from pre-fortification to post-fortification over a 12-year period 
by SF and RCF. Post-fortification SF and RCF were 2.5 times 
and 1.5 times the pre-fortification concentrations, respectively. 
The post-fortification prevalence of low SF (<10 nmol/l) or RCF 
(<340  mol/l) was <1%, compared with 24% for SF and 3.5% for RCC 
before fortification.[4] A comparable reduction in the prevalence of 
subnormal folate concentrations after fortification was subsequently 
reported in population surveys in Canada and other countries 
that had implemented FFF. At the clinical level, US and Canadian 
hospitals reported a fall in the number of patients with low folate 
values following the FFF, with folate-deficient anaemia extremely 
rare.
The effect of FFF in low-income populations likely to suffer from 
nutritional deficiencies, and in target groups such as non-pregnant 
women of reproductive age, pregnant or lactating women, and 
preschool children, has received some but limited attention. The 
increase in SF and RCF in the NHANES study occurred regardless of 
demographic group. In three large county hospitals serving a highly 
indigent population in the USA, the prevalence of low RCF decreased 
from 4.8% in 1997 to 0.65% after FFF. In Canada, FFF increased the 
mean RCF from 527 nmol/l before fortification to 741 nmol/l after 
fortification in women of reproductive age.
In an analysis of dietary surveys on adults in South Africa, mean 
folate intakes were very low, particularly in women, but were raised 
by FFF to above the recommended nutrient intake.[5] This is reflected 
in a study of a small sample of non-pregnant, non-lactating women 
in a rural area in Limpopo Province in which median levels of SF and 
RCF were significantly increased after FFF, the prevalence of low SF 
was reduced from 27.6% to 0%, and the prevalence of low RCF was 
reduced from 26.4% to 1.9%.[6]
Testing for folate deficiency in 
the era of FFF
Folate testing is currently used in the investigation of patients, 
particularly those with anaemia, and in population surveys to 
determine the prevalence of deficiency. In the USA and other 
high-income countries, the majority of folate tests are done to 
investigate macrocytic anaemia in non-pregnant patients. Diagnostic 
laboratories in the USA and Canada have reported a very low 
prevalence of subnormal SF and RCF in patients post FFF, and 
this has provoked calls to reduce or eliminate testing for folate 
deficiency in patients with anaemia and/or macrocytosis. In those 
countries, folate testing could be limited to specific indications such 
as macrocytic anaemia with peripheral blood morphological changes 
suggestive of megaloblastosis, alcoholism, malabsorption syndromes 
such as coeliac disease (most foods fortified with folic acid are 
not gluten free), some haemopoietic disorders, and chemotherapy 
patients. In low-income countries, however, folate deficiency is 
predominantly the result of poor intake, usually associated with 
poverty and malnutrition, coupled with the increasing demand in 
pregnancy; the need for folate testing is therefore much wider, and 
considerably more data are required before limited folate testing can 
be justified.
The value of SF as an index of folate intake or nutritional status 
has been compromised by FFF, and measurement of SF alone is of 
doubtful clinical value. A recent folate-fortified meal may raise a 
subnormal SF to normal and thus mask underlying folate deficiency. 
RCF is not affected by recent intake changes and remains useful in 
clinical settings. It therefore does not seem unreasonable to suggest 
that post FFF, RCF alone be used for the detection of folate deficiency. 
RCF, however, may not detect deficiency of recent onset, for SF falls 
within 3 weeks of consuming a folate-deficient diet, but RCF only 
after 120 days. RCF is not entirely specific for folate deficiency, as 
it may fall also in primary vitamin B12 deficiency, despite adequate 
folate stores. Optimal assessment of folate status after FFF should 
still include both SF and RCF and also serum B12. The extensive 
assessment of folate nutritional status in populations in the USA as 
part of NHANES is carried out by measurement of both SF and RCF, 
and has not changed following the introduction of FFF.
FFF and the implications for patients 
with vitamin B12 deficiency
The metabolic roles of folate and B12 are inextricably linked. In early 
reports (1945 - 1948) large doses of folic acid, 5 mg/day or 30 mg 
3 times a week, produced haematological remission in patients with 
pernicious anaemia (PA), the most important result of B12 deficiency. 
In a high proportion of cases the remission was not sustained and 
neurological relapse was not prevented. In one patient the onset of 
neurological changes was described as ‘explosive’, and the rapidity 
with which neuropathy developed in some patients suggested that 
folic acid not only failed to prevent neuropathy, but was actively 
involved in producing it. This led to concern that the administration 
of folic acid could mask the anaemia and delay the diagnosis of PA, 
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allowing neuropathy to develop and progress. While the evidence that 
folic acid may precipitate neuropathy in patients with B12 deficiency 
is at best debatable, the possibility of masking the anaemia with folic 
acid provided by FFF merits further consideration.
The doses of folic acid that produced haematological remission 
in PA patients are far larger than the amount designed by FFF to 
increase intake to 400 μg/day. In general, PA patients do not show 
haematological response to this dose, but it is possible that no folate 
supplement can be considered safe if it is to be given to PA patients 
over a long period of time.[7]
The usual finding that alerts to the possibility of B12 deficiency is 
macrocytosis, with or without anaemia, and theoretically this could 
be masked by the folic acid in fortified foods. There is evidence 
that this is unlikely, in that the relationship between the serum B12 
concentration and macrocytosis is not influenced by the serum 
folate concentration.[8] It would be expected also that following FFF, 
the number of people with low serum B12 but without macrocytosis 
or anaemia would increase. Reports on this issue are inconsistent. 
In one study,[9] the proportion of patients with low serum B12 but 
without anaemia did not increase significantly after fortification, but 
in another the proportion of subjects with low serum B12 without 
macrocytosis was significantly higher after fortification.[10] One 
disturbing report found that among people with low B12 status in 
the NHANES, high plasma folate was associated with an increased 
prevalence of anaemia and cognitive impairment, and an increase in 
Hcy and methylmalonic acid (an index of B12 nutrition);[11] these data 
imply that high plasma folate is associated with an exacerbation of 
both the biochemical and clinical status of B12 deficiency.
The limited data available to date suggest that large-scale masking 
of B12 deficiency has not occurred following the implementation of 
FFF, and after 15 years of mandatory FFF there is no substantial 
evidence that the higher folic acid intake may harm the public. The 
possibility of delay in the diagnosis of B12 deficiency in patients with 
PA cannot be entirely discounted, and continued monitoring of 
possible deleterious effects is mandatory. The possible masking of 
macrocytosis would be less relevant if clinicians were educated to 
use the readily available measurement of serum B12 for the detection 
of suspected B12 deficiency, as a significant proportion of PA patients 
do not show macrocytosis, especially when there is concomitant 
thalassaemia, iron deficiency, chronic infection, inflammation or 
marked red cell fragmentation.
To avoid a possible deleterious effect of FFF on undetected B12 
deficiency, it has been advocated that B12  be incorporated into 
folate-fortified foods. There are, however, very significant differences 
between the two vitamins. In contrast to folate deficiency, significant 
B12 deficiency is largely confined to malabsorption, usually due to PA, 
a disease predominantly of older age groups, and rarely the result of 
deficient intake, which is seen in vegans. There are large populations 
in the world subsisting on various combinations of vegetarian diets, 
with low B12 contents, among whom the resultant higher prevalence 
of lower serum B12 concentrations does not translate into an increased 
prevalence of anaemia.[12] As significant B12 deficiency is usually due to 
malabsorption, physiological doses of B12 added to food would be of 
questionable value in that they would not be absorbed.
The highest prevalence of low serum B12 concentrations, with 
or without an abnormality in B12-dependent biochemical tests, 
is in older subjects, only a small minority of whom have PA. 
The low serum B12 and/or abnormal biochemical findings are not 
associated with morbidity in that these people rarely if ever develop 
haematological or neurological sequelae of B12 deficiency. This 
so-called subclinical B12 deficiency is usually attributed to food B12 
malabsorption, attendant on various degrees of chronic gastritis; 
low concentrations of the metabolically inert serum B12 binder 
haptocorrin may be a factor in some patients.
Therapeutic trials of oral doses of B12 in older people with subclinical 
B12 deficiency and no evidence of PA have yielded extraordinarily 
varied and controversial results. With test doses of 10 μg and 50 μg 
B12 per day, only the 50 μg dose produced a significant increase in 
serum B12 concentration.[13] In another study, 600 μg B12/day, 300 
times greater than the recommended dietary allowance of 2 μg/day, 
was needed to normalise low serum B12 and raised methylmalonic 
acid.[14] Results in patients with food B12 malabsorption show similar 
variation, one study showing increased serum B12 following a daily 
dose of 5.9 μg,[15] while in another 250 - 1 000 μg/day was required 
to have any effect.[16] Although different degrees of chronic gastritis 
in the patients studied probably contributed to these variable results, 
it is unlikely to account for the remarkable differences reported. The 
field becomes even more confused when the studies of the absorption 
of B12 added to food are considered. Breakfast cereal fortified with 
4.8 μg B12 decreased the prevalence of low serum B12 concentrations 
from 9% to 3%,[17] and bread with 9.6 μg B12 increased the serum 
B12 concentration by 49%.[18] The reason why these relatively small 
amounts of B12 added to food produced an effect, while larger doses 
without food failed to do so, is not apparent. Patients with PA cannot 
respond to normal fortification doses, and as would be expected with 
severe gastric atrophy, doses of 2 000 - 3 000 μg/day are required to 
correct the B12 deficiency.
Regardless of the uncertainties about the amount of B12 to be 
added, Carmel[19] has argued that clinical trials to demonstrate actual 
health benefits of relevant oral doses have not been done in persons 
with subclinical B12 deficiency, who are the only practical targets of B12 
fortification, because more than 94% of persons with clinically overt 
B12 deficiency have severe malabsorption. It is only in the severely 
malabsorptive disorders such as PA, not subclinical deficiency, that 
neurological deterioration following folic acid therapy has been 
described. Extensive work, especially randomised clinical trials, must 
be done before mandatory dietary intervention on a national scale 
can be justified.
Some further issues relating to 
FFF in South Africa
With evidence of widespread folate deficiency in South Africa 
before the implementation of FFF, the efficacy of FFF in reaching all 
sections of the population, especially the target groups of pregnant 
and lactating women and preschool children in low-income groups 
in rural areas, needs to be determined. The results of the study 
of a small group of non-pregnant women in a rural area suggests 
that there is adequate intake of folate-fortified foods,[6] but much 
more data on target groups are needed. Monitoring of fortification 
programmes must include accurate assessment of their effect, as well 
as early detection of possible harm. As mentioned above, the call for 
reduction or elimination of folate testing of patients following FFF, 
emanating from high-income countries, is premature for countries 
in which there are substantial numbers of poor, undernourished 
people, and the goal of FFF reaching the total population has not 
been demonstrated.
The impact of the high prevalence of HIV infection in some 
sections of the population needs to be taken into consideration, for 
there is evidence that HIV infection is prejudicial to folate nutrition. 
In a study of lactating HIV-infected and HIV-uninfected women in 
South Africa, mean folate concentrations were lower in HIV-positive 
mothers. [20] Similar findings had been reported from Zimbabwe, 
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where SF concentrations were lower in HIV-positive women than in 
uninfected women. The cause of the lower folate concentration is not 
clear, but it may be related to malabsorption of folate attendant on the 
changes in the gastrointestinal tract associated with HIV infection. 
Low-income HIV-infected women in their reproductive years, and 
their offspring, could therefore be among the most susceptible to 
folate deficiency.
With regard to the possible masking of B12 deficiency by FFF, in 
most of the surveys of local adults and children, the prevalence of 
subnormal serum B12 has been low, despite the apparent limited intake 
of animal protein in low-income groups. There is no greater potential 
for a harmful effect of FFF in South Africa than anywhere else. It is 
mainly in patients with severe B12 deficiency due to malabsorption, 
such as PA, that there are concerns regarding the masking of B12 
deficiency by FFF. There are no data on the prevalence of PA in 
South Africa, but the disease occurs in all population groups, and the 
prevalence is probably comparable to that reported worldwide.
A further consideration is the possible effect of increased amounts 
of dietary folate overcoming the prophylactic and therapeutic 
effect of antimalarial and chemotherapeutic drugs that act as folate 
antagonists. This is a particular problem for children in malarial 
endemic areas, and has led to the World Health Organization 
warning that supplemental folate should not be given to children 
in whom folate antagonist antimalarial drugs are used. With the 
introduction of newer antimalarial drugs with a different mode of 
action, this should become less of a problem in time.
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